iShares Genomics Immunology and Healthcare ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.47
資產淨值: 745.65
成立日期: 11/06/2019
 
分析
市值分佈:
82.22%
大市值
9.81%
中市值
5.45%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:09) 總持有投資項目: 44  
0%
 
100%
     10大 (51.05%)
代號 名稱 佔比% ▼ 持有日期
IDYAIDEAYA Biosciences2.2930/10/2026
NVAXNovavax1.4630/09/2026
OPHLFOno Pharmaceutical Co., Ltd.1.3930/10/2026
CRSPCRISPR Therapeutics AG1.3730/09/2026
RCUSArcus Biosciences1.3130/10/2026
VIRVir Biotechnology1.3030/10/2026
NUVBNuvation Bio1.0230/10/2026
JANXJanux Therapeutics0.8630/10/2026
PSNLPersonalis0.8430/10/2026
RIGLRigel Pharmaceuticals Inc0.7930/10/2026
KURAKura Oncology0.7630/10/2026
ICVX--0.6531/01/2024
PACBPacific Biosciences of California0.6430/10/2026
XNCRXencor0.5830/10/2026
VSTMVerastem0.5730/09/2026
CRVSCorvus Pharmaceuticals0.5530/10/2026
DNAGinkgo Bioworks Holdings0.4530/10/2026
NTLAIntellia Therapeutics0.4430/09/2026
INRLFValneva SE0.3830/10/2026
CTMXCytomX Therapeutics0.3530/10/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.